Sign In
Free Newsletter
2025: The year of living disruptively
Looking back on 2025, the best symbol of the past year’s upheaval might be the White House, if not its most famous occupant. Since moving back into 1600 Pennsylvania Ave. in January, our real estate mogul president has launched into a series of home renovations worthy of its own HGTV series. The most prominent changes […]
FOR THE RECORD December 2025
Central Virginia Pharmaceutical giants AstraZeneca, Eli Lilly & Co. and Merck & Co. have committed a cumulative $120 million to develop a workforce training center for advanced pharmaceutical manufacturing in Central Virginia. The companies, each of which plans to build major manufacturing facilities in Virginia; the state government, including Virginia Innovation Partnership Corp.; and [...]
Metsera falls after accepting up to $10 billion offer from Pfizer
Pfizer wins a $10 billion deal for weight-loss drugmaker Metsera, ending its bidding war with Danish rival Novo Nordisk.
Stocks slip from records amid trade, tech earnings news
U.S. stocks fell from record highs as investors weighed U.S.-China trade talks and mixed Big Tech earnings from Meta and Microsoft.
Eli Lilly to invest $5B in Goochland plant, creating 650 jobs
Pharmaceutical giant Eli Lilly & Co. plans to invest $5 billion in a manufacturing facility in Goochland County expected to create 650 permanent jobs.
Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications. The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational [&hellip[...]
